Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 17, 2026Reported sale · Form 4Whittemore Tingley, Chief Medical Officer · $1.2KOpen the filing ↗
- Aug 17, 2026Reported sale · Form 4Whittemore Tingley, Chief Medical Officer · $1.2KOpen the filing ↗
- Aug 17, 2026Reported sale · Form 4Whittemore Tingley, Chief Medical Officer · $1.3KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record32716 flagged findings
Reported transactions (Form 4)80since Jan 24, 2025 · and 14 other holdings
Corporate events (8-K)26since Nov 22, 2021
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Listing notice in force
The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Jan 30, 2026).
Deadline: Jul 27, 2026 · passed
- minimum bid price · Nasdaq, rule 5450(a)(1) · notice of Jan 28, 2026 · pending · deadline Jul 27, 2026 (text and rule agree) · first period expired; a second 180-day period may exist that is not on record
Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.
Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.
The 25 most recent filings (of 327)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 13, 26PRE 14A ↗Shareholder meeting and votes new
- Aug 24, 26SCHEDULE 13G ↗Passive stake · Integrated Core Strategies (US) LLC · 5.2% · event on Aug 17, 26
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Aug 17, 26Form 144 ↗Notice of proposed sale
- Aug 17, 26Form 144 ↗Notice of proposed sale
- Aug 5, 2610-Q ↗Quarterly report
- Aug 5, 268-K ↗Current report · Results
- Jul 14, 26Form 3 ↗Insider transaction
- Jul 14, 26Form 4 ↗Insider transaction
- Jul 2, 268-K ↗Current report · A material agreement was terminated
- Jun 29, 268-K ↗Current report · A senior executive left or was appointed
Insider transaction · 7 Form 4 filingsshow all 7hide
- May 29, 268-K ↗Current report · A senior executive left or was appointed
327 filings on record, the oldest from Jun 3, 21.
Listing the 25 most recent filings of the 327 on record.
4715
- Jul 2, 26A material agreement was terminated8-K 1.02 ↗
- Jun 29, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 29, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Mar 5, 26Entered a material agreement8-K 1.01 ↗
- Jan 30, 26Listing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
- Jan 2, 26A senior executive left or was appointed8-K 5.02 ↗
- Dec 12, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Apr 18, 25Listing notice (8-K 3.01)8-K 3.01 ↗
- Mar 28, 25Restructuring plan with committed costs8-K 2.05 ↗
- Mar 4, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
7 senior executive changes2024 – 2025show all 7hide
- Feb 7, 25A senior executive left or was appointed8-K 5.02 ↗
- Jan 28, 25A senior executive left or was appointed8-K 5.02 ↗
- Dec 17, 24A senior executive left or was appointed8-K 5.02 ↗
- Sep 16, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Aug 8, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jul 25, 24A senior executive left or was appointed8-K 5.02 ↗
- Jun 27, 24A senior executive left or was appointed8-K 5.02 ↗
- May 14, 24Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
7 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Tim Kutzkey25.4%Feb 10, 26SCHEDULE 13D/A ↗8 co-filers on this document — the figure is the largest single stake, not their sum.
- The Column Group Opportunity III, LP23.1%Feb 25, 26SCHEDULE 13D/A ↗8 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
- Casdin Capital, LLC4.3%Mar 4, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Integrated Core Strategies (US) LLC5.2%Aug 17, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Woodline Partners LP5.0%Jun 30, 25SCHEDULE 13G/A ↗1 earlier filing
- Empery Asset Management, LP5.0%Jun 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- JPMORGAN CHASE & CO.2.8%Feb 28, 25SCHEDULE 13G/A ↗1 earlier filing
- BlackRock, Inc.1.7%Jun 30, 25SCHEDULE 13G/A ↗1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Aug 17, Faraz Ali filed notice of intent to sell up to $16K.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $16K across 4 trades on Aug 17, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+1 more recent notices · 1 with a later sale
- Aug 17, 26Sell$1KWhittemore TingleyChief Medical Officer↗
- Aug 17, 26Sell$1KWhittemore TingleyChief Medical Officer↗
- Aug 17, 26Sell$1KWhittemore TingleyChief Medical Officer↗
- Aug 17, 26Sell$2KWhittemore TingleyChief Medical Officer↗
- Aug 17, 26Sell$4KFaraz AliChief Executive Officer↗
- Aug 17, 26Sell$3KFaraz AliChief Executive Officer↗
- Aug 17, 26Sell$4KFaraz AliChief Executive Officer↗
- Aug 17, 26Sell$5KFaraz AliChief Executive Officer↗
- May 18, 26Sell$1KTomohiro HigaSVP, Finance↗
- May 18, 26Sell$2KWhittemore TingleyChief Medical Officer↗
- May 18, 26Sell$3KFaraz AliChief Executive Officer↗
- Feb 25, 26Sell$928KCOLUMN GROUP III GP, LP↗
There are 23 more transactions in this stretch.
Stock compensation, tax and giftsshow the 5 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 10, 26Compensationamount n/aWhittemore TingleyChief Medical Officer↗
- Sep 10, 26Compensationamount n/aFaraz AliChief Executive Officer↗
- Feb 3, 26Compensationamount n/aFaraz AliChief Executive Officer↗
- Feb 3, 26Compensationamount n/aWhittemore TingleyChief Medical Officer↗
- Feb 3, 26Compensationamount n/aTomohiro HigaSVP, Finance↗
The full record holds 103 transactions and goes back to Jan 17, 23.
Its sector and its market
Tenaya Therapeutics, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Tenaya Therapeutics, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Tenaya Therapeutics, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 327 documents on file, from Jun 3, 2021 to Oct 13, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.